Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.75%
- Poor long term growth as Net Sales has grown by an annual rate of -6.18% and Operating profit at -153.44% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Negative results in Mar 25
3
Risky -
4
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
89.37%
0%
89.37%
6 Months
80.83%
0%
80.83%
1 Year
60.87%
0%
60.87%
2 Years
51.74%
0%
51.74%
3 Years
32.51%
0%
32.51%
4 Years
49.38%
0%
49.38%
5 Years
14.8%
0%
14.8%
Shenzhen Neptunus Bioengineering Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-6.18%
EBIT Growth (5y)
-153.44%
EBIT to Interest (avg)
0.55
Debt to EBITDA (avg)
21.96
Net Debt to Equity (avg)
4.87
Sales to Capital Employed (avg)
2.05
Tax Ratio
6.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.75%
ROE (avg)
2.85%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.58
EV to EBIT
-172.11
EV to EBITDA
91.12
EV to Capital Employed
1.47
EV to Sales
0.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.85%
ROE (Latest)
-40.35%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
6,916.30
7,356.50
-5.98%
Operating Profit (PBDIT) excl Other Income
238.00
193.70
22.87%
Interest
150.50
147.10
2.31%
Exceptional Items
0.00
0.00
Consolidate Net Profit
11.90
53.00
-77.55%
Operating Profit Margin (Excl OI)
26.60%
19.00%
0.76%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -5.98% vs 28.23% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -77.55% vs 104.10% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
30,219.20
36,311.70
-16.78%
Operating Profit (PBDIT) excl Other Income
423.00
700.30
-39.60%
Interest
850.90
992.40
-14.26%
Exceptional Items
-471.40
-909.60
48.18%
Consolidate Net Profit
-1,167.30
-1,719.00
32.09%
Operating Profit Margin (Excl OI)
5.40%
11.10%
-0.57%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -16.78% vs -3.76% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 32.09% vs -73.39% in Dec 2023
About Shenzhen Neptunus Bioengineering Co., Ltd. 
Shenzhen Neptunus Bioengineering Co., Ltd.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






